2025 Annual Meeting | PL2 - Hot Topics Plenary Session

Date Saturday 04/05/25

Time 04:45 PM - 05:45 PM PDT Add To Calendar

Location San Diego Convention Center | Ballroom 20

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Reena P. Thomas, MD, PhD, FAAN

Topic(s) General Neurology

Learning Objectives This session highlights the latest, cutting-edge translational research related to clinical issues of importance with three outstanding speakers providing summaries of their recent research findings and describing the clinical implications of the results.

CME Available 1.00 CME credit

Program Materials Program Evaluations

Event Timeline
04:45 PM - 05:05 PM PDT	Speaker	AI and Biomarkers for Early Disease Detection Stephanie R. Miller, PhD
05:05 PM - 05:25 PM PDT	Speaker	GLP1 Receptor Agonists: A Panacea or Too Good to Be True? Paul Edison, MBBS, PhD, FRCPI
05:25 PM - 05:45 PM PDT	Speaker	Implantable Brain-Computer Interfaces for the Restoration of Communication and Mobility Leigh R. Hochberg, MD, PhD, FAAN

Faculty Disclosures
Reena P. Thomas, MD, PhD, FAAN	The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.
Stephanie R. Miller, PhD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cambrya, LLC. Dr. Miller has received research support from Gladstone Institutes. Dr. Miller has received research support from National Institutes of Health.
Paul Edison, MBBS, PhD, FRCPI	No disclosure on file
Leigh R. Hochberg, MD, PhD, FAAN	The institution of Dr. Hochberg has received research support from The MGH Translational Research Center has a clinical research support agreement (CRSA) with Axoft, Neuralink, Neurobionics, Precision Neuro, Synchron, and Reach Neuro, for which LRH provides consultative input. LRH is a non-compensated member of the Board of Directors of a nonprofit assistive communication device technology foundation (Speak Your Mind Foundation). Mass General Brigham (MGB) is convening the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC); charitable gift agreements to MGB, including those received to date from Paradromics, Synchron, Precision Neuro, Neuralink, and Blackrock Neurotech, support the iBCI-CC, for which LRH provides effort.. The institution of Dr. Hochberg has received research support from Dr. Hochberg also receives research support from the US Department of Veterans Affairs and the National Institutes of Health.. Dr. Hochberg has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��

��ɫ��